Susquehanna International Group, LLP Vertex Pharmaceuticals Inc Call Options Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

Call Options

28 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 15, 2024	BUY	$392.81 - $485.53 $15.3 Million - $18.9 Million	38,900 Added 15.25%	293,900 $138 Million
Q1 2024 May 07, 2024	SELL	$407.69 - $446.08 $112 Million - $122 Million	-274,500 Reduced 51.84%	255,000 $107 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $8.61 Million - $10.3 Million	25,100 Added 4.98%	529,500 $215 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $66.7 Million - $71.4 Million	197,100 Added 64.14%	504,400 $175 Million
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $9.15 Million - $10.2 Million	29,100 Added 10.46%	307,300 $108 Million
Q1 2023 May 16, 2023	SELL	$283.23 - $323.1 $12.6 Million - $14.4 Million	-44,500 Reduced 13.79%	278,200 $87.7 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $29.1 Million - $32.8 Million	-101,900 Reduced 24.0%	322,700 $93.2 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $16.1 Million - $17.9 Million	58,700 Added 16.04%	424,600 $123 Million
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $33.8 Million - $42.1 Million	-144,000 Reduced 28.24%	365,900 $103 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $8.72 Million - $10.3 Million	-39,400 Reduced 7.17%	509,900 $133 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $9.1 Million - $11.5 Million	-51,400 Reduced 8.56%	549,300 $121 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $47.5 Million - $53.1 Million	-261,800 Reduced 30.35%	600,700 $109 Million
Q2 2021 Aug 11, 2021	BUY	$187.49 - $221.1 $74.1 Million - $87.3 Million	395,000 Added 84.49%	862,500 $174 Million
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $58.2 Million - $67.8 Million	281,100 Added 150.8%	467,500 $100 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $621,030 - $828,269	3,000 Added 1.64%	186,400 $44.1 Million
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $9.15 Million - $10.9 Million	-35,800 Reduced 16.33%	183,400 $49.9 Million
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $25 Million - $32.8 Million	-110,900 Reduced 33.6%	219,200 $63.6 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $43.7 Million - $54.2 Million	218,600 Added 196.05%	330,100 $78.5 Million
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $33.4 Million - $44.8 Million	-200,200 Reduced 64.23%	111,500 $24.4 Million
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $6.75 Million - $7.6 Million	40,600 Added 14.98%	311,700 $52.8 Million
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $7.51 Million - $8.68 Million	45,600 Added 20.22%	271,100 $49.7 Million
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $98.5 Million - $117 Million	-601,700 Reduced 72.74%	225,500 $41.5 Million
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $50.1 Million - $63.4 Million	330,100 Added 66.41%	827,200 $137 Million
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $13.1 Million - $15.1 Million	78,300 Added 18.7%	497,100 $95.8 Million
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $16.8 Million - $19.6 Million	115,600 Added 38.13%	418,800 $71.2 Million
Q1 2018 May 15, 2018	BUY	$151.6 - $177.13 $742,840 - $867,937	4,900 Added 1.64%	303,200 $49.4 Million
Q4 2017 Feb 14, 2018	SELL	$137.28 - $155.55 $76.6 Million - $86.8 Million	-558,300 Reduced 65.18%	298,300 $44.7 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $127 Million - $139 Million	856,600	856,600 $130 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

Capital World Investors Los Angeles, CA

26.7M
Shares

$13.4 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$11.5 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10.7 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$5.89 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.29 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account